WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 15-July-2016 (15-July-2016)
Next overall update Fall 2016
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 27'0901 Infant (under 12 months) mortality rate: 32
GDP / capita (US$): 34'3561 Child (under 5 years) mortality rate: 32

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 50'293  50'074  49'847  49'608  49'357  46'206  42'972  37'451 
Births 457  456  456  456  457  543  670  813 
Surviving infants 456  455  455  455  456  540  662  789 
Pop. less than 5 years 2'287  2'287  2'304  2'324  2'321  3'145  3'241  3'836 
Pop. less than 15 years 7'037  7'167  7'346  7'564  7'786  9'685  11'014  12'703 
Female 15-49 years 12'677  12'803  12'903  12'980  13'046  13'219  12'282  9'885 

Number of reported cases

(Click for retrospective incidence data for Republic of Korea (the))
Diphtheria
ChartChart
  51 
Japanese encephalitis
ChartChart
  40  26  14  20 
Measles
ChartChart ChartChart
  442  107  42  32'647  3'415  5'097 
Mumps
ChartChart
  17'022  7'147  6'241  3'057 
Pertussis
ChartChart
  205  76  36  230  97  28  174  1'554 
Polio*
ChartChart
  14 
Rubella
ChartChart
  11  17  27  53  153 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  22  26  22  17  19 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Republic of Korea (the))
Vaccine year result method % card seen                                                
BCG          98  99*  99*  99*  99  73  72 
DTP1          99  99*  99*  99*  99*  97 
DTP3          98  99*  99*  99*  99  97  74  70 
DTP4          96  97 
IPV1          99 
HepB_BD          93  92  93 
HepB3          98  99  99  99  99  93 
Hib3          98  97 
JapEnc          97  99  99  99  98 
MCV1          98  99*  99*  99  99  95  93 
MCV2          97  96  95  97  98  39 
PCV1          99 
PCV3          97 
Pol3          98  99  99  99  98  99  74  89 
Rota1         
RotaC         
Rubella1          98  99*  99*  99  99 
TT2plus         
PAB         
VAD1         
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Republic of Korea (the))
BCG
ChartChart
  98  99  99  99  99  73  72 
DTP1
ChartChart
  99  99  99  99  99  97  90 
DTP3
ChartChart
  98  99  99  99  99  97  74 
HepB3
ChartChart
  98  99  99  99  99  93 
HepB_BD
ChartChart
  93  92 
Hib3
ChartChart
  98  97 
MCV1
ChartChart
  98  99  99  99  99  95  93 
MCV2
ChartChart
  97  96  95  97  98  39 
PCV3
ChartChart
  97 
Pol3
ChartChart
  98  99  99  99  98  99  74 
RCV1
ChartChart
  98  99  99  99  99  95  93 
RotaC
ChartChart
 

Number of districts in the country 255  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth-1 month; Yes
DTaP 2, 4, 6, 15-18 months; 4-6 years; Yes
DTaPIPV 2, 4, 6 months; 4-6 years; Yes
HFRS 1st contact, +1months; +1 year; Yes high risk group
HIB 2, 4, 6 months; Yes
HPV 11-12 years; +6 months; Yes June 2016
HepA 12-23 months; +6-+12 months; Yes
HepB birth; 1, 6 months; Yes
IPV 2, 4, 6 months; 4-6 years; Yes
Influenza_Adult >=Y50 Yes and adults with chronic illness, pregnant women, health care workers, and any other risk group
Influenza_Pediatric 6-59 months; Yes and children with chronic illness
JE_Inactd 12-23 months; +7-+30 days; +12 months; 6, 12 years; Yes
JE_LiveAtd 12-23, 34-35 months; Yes
MMR 12-15 months; 4-6 years; Yes
Pneumo_conj 2, 4, 6, 12-15 months; Yes
Pneumo_ps >=65 years; Yes and High risk groups (children over 2 years)
Td 11-12 years; (x2) Yes
Tdap 11-12 years; (x2) Yes
Typhoid Yes high risk group
Varicella 12-15 months; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number   3 years  2008-2012  2008-2012  2008-2012  2008-2012  2008-1012 
Nº of districts with microplans that include activities to raise immunization coverage number 255             

System performance

Total Nº districts in country number 255  254  254    230  270  270 
Nº districts with DTP3 coverage >=80% number 255        270  270 
% of districts with DTP3 coverage >=80% From 0 to 100% 100          100  100 
Nº districts with measles (MCV1) coverage >=95% number 235           
% of districts with MCV1 coverage >=95% From 0 to 100% 92             

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100        52  48  40 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.